Literature DB >> 33746333

Integrative radiomic analysis for pre-surgical prognostic stratification of glioblastoma patients: from advanced to basic MRI protocols.

Spyridon Bakas1, Gaurav Shukla1, Hamed Akbari1, Guray Erus1, Aristeidis Sotiras2, Saima Rathore1, Chiharu Sako1, Sung Min Ha2, Martin Rozycki3, Ashish Singh1, Russell Shinohara4, Michel Bilello1, Christos Davatzikos1.   

Abstract

Glioblastoma, the most common and aggressive adult brain tumor, is considered non-curative at diagnosis. Current literature shows promise on imaging-based overall survival prediction for patients with glioblastoma while integrating advanced (structural, perfusion, and diffusion) multipara metric magnetic resonance imaging (Adv-mpMRI). However, most patients prior to initiation of therapy typically undergo only basic structural mpMRI (Bas-mpMRI, i.e., T1,T1-Gd,T2,T2-FLAIR) pre-operatively, rather than Adv-mpMRI. Here we assess a retrospective cohort of 101 glioblastoma patients with available Adv-mpMRI from a previous study, which has shown that an initial feature panel (IFP) extracted from Adv-mpMRI can yield accurate overall survival stratification. We further focus on demonstrating that equally accurate prediction models can be constructed using augmented feature panels (AFP) extracted solely from Bas-mpMRI, obviating the need for using Adv-mpMRI. The classification accuracy of the model utilizing Adv-mpMRI protocols and the IFP was 72.77%, and improved to 74.26% when utilizing the AFP on Bas-mpMRI. Furthermore, Kaplan-Meier analysis demonstrated superior classification of subjects into short-, intermediate-, and long-survivor classes when using AFPon Basic-mpMRI. This quantitative evaluation indicates that accurate survival prediction in glioblastoma patients is feasible by using solely Bas-mpMRI and integrative radiomic analysis can compensate for the lack of Adv-mpMRI. Our finding holds promise for predicting overall survival based on commonly-acquired Bas-mpMRI, and hence for potential generalization across multiple institutions that may not have access to Adv-mpMRI, facilitating better patient selection.

Entities:  

Keywords:  glioblastoma; multivariate; prediction; prognosis; radiomics; survival

Year:  2020        PMID: 33746333      PMCID: PMC7971448          DOI: 10.1117/12.2566505

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  16 in total

1.  A robust framework for soft tissue simulations with application to modeling brain tumor mass effect in 3D MR images.

Authors:  Cosmina Hogea; George Biros; Feby Abraham; Christos Davatzikos
Journal:  Phys Med Biol       Date:  2007-11-08       Impact factor: 3.609

2.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.

Authors:  Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

3.  Imaging and genomics: is there a synergy?

Authors:  C Carl Jaffe
Journal:  Radiology       Date:  2012-08       Impact factor: 11.105

4.  Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.

Authors:  Spyridon Bakas; Hamed Akbari; Aristeidis Sotiras; Michel Bilello; Martin Rozycki; Justin S Kirby; John B Freymann; Keyvan Farahani; Christos Davatzikos
Journal:  Sci Data       Date:  2017-09-05       Impact factor: 6.444

5.  Glioblastoma survival in the United States before and during the temozolomide era.

Authors:  Derek R Johnson; Brian Patrick O'Neill
Journal:  J Neurooncol       Date:  2011-11-02       Impact factor: 4.130

6.  An image-driven parameter estimation problem for a reaction-diffusion glioma growth model with mass effects.

Authors:  Cosmina Hogea; Christos Davatzikos; George Biros
Journal:  J Math Biol       Date:  2007-11-17       Impact factor: 2.259

7.  Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome.

Authors:  Christos Davatzikos; Saima Rathore; Spyridon Bakas; Sarthak Pati; Mark Bergman; Ratheesh Kalarot; Patmaa Sridharan; Aimilia Gastounioti; Nariman Jahani; Eric Cohen; Hamed Akbari; Birkan Tunc; Jimit Doshi; Drew Parker; Michael Hsieh; Aristeidis Sotiras; Hongming Li; Yangming Ou; Robert K Doot; Michel Bilello; Yong Fan; Russell T Shinohara; Paul Yushkevich; Ragini Verma; Despina Kontos
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-11

8.  Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma.

Authors:  Michel Bilello; Hamed Akbari; Xiao Da; Jared M Pisapia; Suyash Mohan; Ronald L Wolf; Donald M O'Rourke; Maria Martinez-Lage; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2016-03-12       Impact factor: 4.881

Review 9.  The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review.

Authors:  Hugo J W L Aerts
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

Review 10.  The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS).

Authors:  Bjoern H Menze; Andras Jakab; Stefan Bauer; Jayashree Kalpathy-Cramer; Keyvan Farahani; Justin Kirby; Yuliya Burren; Nicole Porz; Johannes Slotboom; Roland Wiest; Levente Lanczi; Elizabeth Gerstner; Marc-André Weber; Tal Arbel; Brian B Avants; Nicholas Ayache; Patricia Buendia; D Louis Collins; Nicolas Cordier; Jason J Corso; Antonio Criminisi; Tilak Das; Hervé Delingette; Çağatay Demiralp; Christopher R Durst; Michel Dojat; Senan Doyle; Joana Festa; Florence Forbes; Ezequiel Geremia; Ben Glocker; Polina Golland; Xiaotao Guo; Andac Hamamci; Khan M Iftekharuddin; Raj Jena; Nigel M John; Ender Konukoglu; Danial Lashkari; José Antonió Mariz; Raphael Meier; Sérgio Pereira; Doina Precup; Stephen J Price; Tammy Riklin Raviv; Syed M S Reza; Michael Ryan; Duygu Sarikaya; Lawrence Schwartz; Hoo-Chang Shin; Jamie Shotton; Carlos A Silva; Nuno Sousa; Nagesh K Subbanna; Gabor Szekely; Thomas J Taylor; Owen M Thomas; Nicholas J Tustison; Gozde Unal; Flor Vasseur; Max Wintermark; Dong Hye Ye; Liang Zhao; Binsheng Zhao; Darko Zikic; Marcel Prastawa; Mauricio Reyes; Koen Van Leemput
Journal:  IEEE Trans Med Imaging       Date:  2014-12-04       Impact factor: 10.048

View more
  1 in total

1.  Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1.

Authors:  Rhea Chitalia; Sarthak Pati; Megh Bhalerao; Siddhesh Pravin Thakur; Nariman Jahani; Vivian Belenky; Elizabeth S McDonald; Jessica Gibbs; David C Newitt; Nola M Hylton; Despina Kontos; Spyridon Bakas
Journal:  Sci Data       Date:  2022-07-23       Impact factor: 8.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.